State of Wyoming’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.6K Buy
+441
New +$44.3K 0.01% 1687
2026
Q1
– Sell
-4,687
Closed -$370K – 1947
2025
Q4
$370K Buy
+4,687
New +$336K 0.04% 574
2025
Q3
– Sell
-202
Closed -$10.3K – 1970
2025
Q2
$10.3K Buy
+202
New +$8.99K ﹤0.01% 1761
2022
Q3
– Sell
-773
Closed -$15K – 1769
2022
Q2
$15K Buy
773
+555
+255% +$13.1K 0.01% 1541
2022
Q1
$5K Buy
218
+183
+523% +$3.73K ﹤0.01% 1661
2021
Q4
$1K Sell
35
-2
-5% -$31 ﹤0.01% 1814
2021
Q3
$1K Sell
37
-18
-33% -$293 ﹤0.01% 1185
2021
Q2
$1K Buy
+55
New +$986 ﹤0.01% 1138

Other funds holding MIRM

State of Wyoming's MIRM Position: Q2 2026 in Review

State of Wyoming opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 441 shares worth $51.6K. The stake represents 0.01% of the portfolio and ranks #1687 among its holdings. This is a return to the name: State of Wyoming previously reported a position in MIRM as recently as Q4 2025.

State of Wyoming first reported a position in MIRM in Q2 2021 and has held it in 8 quarters since. The position peaked at $370K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • State of Wyoming held 441 shares of Mirum Pharmaceuticals worth $51.6K as of Q2 2026.
  • Mirum Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • Mirum Pharmaceuticals made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1687 holding.
  • State of Wyoming first reported a position in Mirum Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
  • State of Wyoming's Mirum Pharmaceuticals position peaked at $370K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.